Evaluate the Pharmacokinetic Characteristics and Safety/Tolerability of YNP-1807 Compared to Lyrica® After Oral Administration Adult Volunteers
Clinical trial NCT03261427 · COMPLETED
Trial details
- NCT number
- NCT03261427
- Sponsor
- Yungjin Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-14
- Primary completion
- 2017-10-11
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.